Live Breaking News & Updates on Visual Evoked Potential

Stay updated with breaking news from Visual evoked potential. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

"Conflict and control in cortical responses to inconsistent emotional s" by Graham A. Jamieson, Julia Page et al.

Social communication is fraught with ambiguity. Negotiating the social world requires interpreting the affective signals we receive and often selecting between channels of conflicting affective information. The affective face-word Stroop (AFWS) provides an experimental paradigm which may identify cognitive-affective control mechanisms underpinning essential social-affective skills. Initial functional magnetic resonance imaging (fMRI) study of the AFWS identified right amygdala as driving this affective conflict and left rostral anterior cingulate cortex (rACC) as the locus of conflict control. We employed electroencephalogram (EEG) and eLORETA source localization to investigate the timing, location, and sequence of control processes when responding to affective conflict generated during the AFWS. However we designated affective word as the response target and affective face as the distractor to maximize conflict and control effects. Reaction times showed slowed responses in high vs. lo ....

Visual Evoked Potential , Affective Control , Ffective Stroop , Fusiform Face Area , Ostral Acc ,

LumiThera Inc.: LumiThera, Inc. Announces Purchase of MacuLogix Assets

LumiThera Inc.: LumiThera, Inc. Announces Purchase of MacuLogix Assets
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Clarke Tedford , Kostenloser Wertpapierhandel , Greg Jackson , Maculogix Inc , Diopsys Inc , Lumithera Inc , Excellence Program , European Union , Food Drug Administration , Prnewswire Lumithera Inc , Thera Inc , Age Related Macular Degeneration , Adaptdx Pro , Maculogix Chief Technology Officer , Evoked Potential , Visual Evoked Potential , Delivery System , Valeda Light Delivery System , Drug Administration ,